Related Experiment Video
Updated: May 7, 2025
Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
Published on: April 26, 2012
Compression Therapy for Prevention of Chemotherapy-Induced Peripheral Neuropathy: A Systematic Review and
Zhanhai Wan1, Jiajie Huang2, Xiumei Wang1
1Department of Anesthesiology and Operating Theater, The First Hospital of LanZhou University, Lanzhou, Gansu, People's Republic of China.
Background:
Chemotherapy-induced peripheral neuropathy (CIPN) significantly impairs the quality of life of patients undergoing chemotherapy and diminishes their adherence to the treatment regimen. Existing studies suggest that compression therapy may prevent the onset of CIPN, yet the specific efficacy remains to be conclusively determined.
Methods:
We performed a systematic review and meta-analysis of randomized controlled trials (RCTs) comparing compression therapy with inactive comparators in patients scheduled for chemotherapy. Evidence certainty was evaluated using the GRADE approach.
Results:
Analysis of four trials (442 patients) revealed that compression therapy reduced CIPN incidence (RR = 0.50, 95% CI: 0.33-0.76; absolute effect = -265, 95% CI: -355 to -127 per 1000) and depression (SMD = -0.83, 95% CI: -1.21 to -0.45) with moderate evidence and high adherence. No significant differences emerged in anxiety, sleep quality, or pain.
Conclusion:
Moderate- to low-certainty evidence supports compression therapy's effectiveness in preventing CIPN and alleviating depression while showing no substantial impact on other outcomes.
Limitation:
Evidence quality and quantity suggest potential bias, warranting additional RCTs to strengthen the evidence base.
More Related Videos
05:56Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
Published on: June 21, 2024
05:18Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
Published on: May 26, 2023
Related Concept Videos
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...